Frances K Nally

Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype

S. Cryan, C. McCoy, J. Dowling, 2022, Molecular therapy. Nucleic acids.

Nanomodulation of Macrophages in Multiple Sclerosis

C. McCoy, C. de Santi, Frances K Nally, 2019, Cells.

Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages

Linden J. Gearing, David K. Finlay, P. Oefner, 2021, Nature Communications.